The reality of this situation is very simple. In its current state, Poet (whether we like it or not) is not in a position to approach a tier 1 bank for conventional financing. Bankers don't look at things like us shareholders, their brains work differently.

As a result, TM out of necessity, was required to look at alternative sources of creative financing which unfortunately come at a higher price due in large part to the inherent risks associated with Poet.

What is important, and it has been expressed by others, is that a bank and the debenture holders (including insiders) demonstrated enough confidence that the Denselight transaction will in fact close and they will be repaid because no reasonable  amount of interest (something less than loansharking) will offset an investor's perceived risk associated with not being repaid.

That's the way I see it anyways. At the end of the day, none of this financing nor the proceeds raised from the Denselight sale matter unless the Opitcal Interposer platform can produce $$$$.

Hogan